MILIFE CARE Trademark

Trademark Overview


On Monday, June 30, 2025, a trademark application was filed for MILIFE CARE with the United States Patent and Trademark Office. The USPTO has given the MILIFE CARE trademark a serial number of 99260363. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, May 8, 2026. This trademark is owned by Asahi Kasei Medical Co., Ltd.. The MILIFE CARE trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments for use in apheresis, namely, blood filters for separating blood plasma for medical purposes and structural and replacement parts and fittings therefor, and blood filters for fractionating blood plasma components for medical purposes and structural and replacement parts and fittings therefor for use in extracorporeal circulation during heart and kidney surgery and intensive care; blood component adsorber, namely, immunoadsorption columns being medical devices for removing pathogenic substances directly from a patient's plasma for therapeutic use and structural and replacement parts and fittings therefor; none of the foregoing goods being in the nature of, or related to, personal protective equipment in the nature of masks, infusion and injection apparatus, and insulin pumps, or in the field of diabetes care in general
milife care

General Information


Serial Number99260363
Word MarkMILIFE CARE
Filing DateMonday, June 30, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, May 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"CARE"
Goods and ServicesMedical instruments for use in apheresis, namely, blood filters for separating blood plasma for medical purposes and structural and replacement parts and fittings therefor, and blood filters for fractionating blood plasma components for medical purposes and structural and replacement parts and fittings therefor for use in extracorporeal circulation during heart and kidney surgery and intensive care; blood component adsorber, namely, immunoadsorption columns being medical devices for removing pathogenic substances directly from a patient's plasma for therapeutic use and structural and replacement parts and fittings therefor; none of the foregoing goods being in the nature of, or related to, personal protective equipment in the nature of masks, infusion and injection apparatus, and insulin pumps, or in the field of diabetes care in general

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsahi Kasei Medical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTokyo 100-0006
JP

Trademark Events


Event DateEvent Description
Monday, June 30, 2025NEW APPLICATION ENTERED
Monday, June 30, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, November 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 18, 2025ASSIGNED TO EXAMINER
Saturday, November 29, 2025NON-FINAL ACTION WRITTEN
Saturday, November 29, 2025NON-FINAL ACTION E-MAILED
Saturday, November 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 19, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, February 19, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 8, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 8, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 12, 2026TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 12, 2026PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED